Hydrogen's Feasibility and Safety as a Therapy in ECPR

Recruiting Phase 1 Interventional Study
Cardiac Arrest Extracorporeal Membrane Oxygenation Reperfusion Injury
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
53 (estimated)
Sponsor
Boston Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiring extracorporeal cardiopulmonary resuscitation (ECPR, i.e. mechanical circulatory support). Under exemption from informed consent, patients undergoing refractory cardiac arrest in the cardiac ICU at a participating center will be randomized…
Trial Locations

Sorted by distance from Kentucky

Loading…

Loading trial locations…

Eligibility Criteria
INCLUSION CRITERIA In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Patients admitted to a cardiac intensive care unit at a participating site with cardiac comorbidity, including congenital heart disease, myocarditis, cardiac arrhythmi…
Contacts

John N Kheir, MD

8576368890

john.kheir@childrens.harvard.edu

CONTACT

Victoria Habet, DO

CONTACT